Medicare has historically excluded weight-loss drugs by statute, though the Medicare GLP-1 Bridge demonstration (announced for July 2026) is set to cover Wegovy and Zepbound for eligible Part D beneficiaries at a $50/month copay, with the longer-term BALANCE Model launching in Part D in January 2027
It works even better when used alongside glycolic acid
Andrology 11 , 987996 (2023)
We help set realistic expectations for women after 40: GLP-1s, Hormones & Menopause
Medicaid covers GLP-1 weight loss injections like Wegovy, Ozempic, and Zepbound in some states but not others
Helpful habits include: Planning balanced meals in advance Drinking enough water every day Staying physically active throughout the week Tracking your progress with measurements and photos Managing stress effectively Following your healthcare provider's recommendations Attending regular follow-up appointments These habits can help maintain results long after the initial weight loss phase